How Altimmune Inc. (ALT) Works From A Technical Perspective

0
10

Altimmune Inc. (NASDAQ:ALT) finished Wednesday with an addition of $0.09 to close at $12.69, an upside of 0.71 percent. An average of 4,678,520 shares of common stock have been traded in the last five days. There was a fall of -$2.18 in the past week, and it reached a new high 9 times over the past 12 months. The last 20 days have seen an average of 4,617,595 shares traded, while the 50-day average volume stands at 2,759,520.

ALT stock has decreased by -28.31% in the last month. The company shares reached their 1-month lowest point of $11.16 on 09/14/22. With the stock rallying to its 52-week high on 09/02/22, shares of the company touched a low of $3.83 and a high of $23.49 in 52 weeks. It has reached a new high 19 times so far this year and achieved 38.54% or $3.53 in price. In spite of this, the price is down -45.98% from the 52-week high.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored


Insider Transactions

22 days have passed since Altimmune Inc. (ALT) last reported insider trading activity. Garg Vipin K, who is President and CEO, most recently acquired $20,000 shares at $20.02 per share on Aug 31. In this transaction, the insider spent $400,322. President and CEO, Garg Vipin K, disposed of 15,000 shares at a price of $15.06 on Aug 12. The insider now owns more than $225,890 worth of shares. Prior to that, Chief Scientific Officer Roberts M Scot went on to Sale 10,182 shares at $12.00 each on Jul 05. An amount of $122,184 was transacted.

Valuation Metrics

Altimmune Inc. (ALT) stock’s beta is 0.25. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 187.12, the price-to-book (PB) ratio at 3.10.

Financial Health

The quick ratio of Altimmune Inc. for the three months ended June 29 was 14.10, and the current ratio was 14.10, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the quarter ending June 29. Its gross profit as reported stood at $101.32 million compared to revenue of $4.41 million.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Altimmune Inc.’s return on assets was -44.50%.

Earnings Surprise

The analyst consensus anticipated Altimmune Inc.’s latest quarter earnings to come in at -$0.47 per share, but it turned out to be -$0.42, a 10.60% surprise. For the quarter, EBITDA amounted to -$20.34 million. Shareholders own equity worth $48.53 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Altimmune Inc. (ALT) price momentum. RSI 9-day as of the close on 21 September was 24.52%, suggesting the stock is oversold, with historical volatility in this time frame at 153.64%.

As of today, ALT’s price is $13.23 -14.66% or -$2.18 from its 5-day moving average. ALT is currently trading -31.14% lower than its 20-day SMA and +176.47% higher than its 100-day SMA. However, the stock’s current price level is +11.81% above the SMA50 and +33.86% above the SMA200.

The stochastic %K and %D were 12.52% and 15.90%, respectively, and the average true range (ATR) was 2.12. With the 14-day stochastic at 12.41% and the average true range at 2.03, the RSI (14) stands at 33.26%. The stock has reached -3.06 on the 9-day MACD Oscillator while the 14-day reading was at -4.92.

What is ALT’s price target for the next 12 months?

Analysts predict a range of price targets between $14.00 and $50.00, with a median target of $26.00. Taking a look at these predictions, the average price target given by analysts for Altimmune Inc. (ALT) stock is $29.14.

LEAVE A REPLY

Please enter your comment!
Please enter your name here